Fred Alger Management’s Madrigal Pharmaceuticals MDGL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-93,446
| Closed | -$19.8M | – | 448 |
|
|
2024
Q3 | $19.8M | Sell |
93,446
-9,009
| -9% | -$1.91M | 0.1% | 134 |
|
|
2024
Q2 | $28.7M | Buy |
102,455
+37,879
| +59% | +$10.6M | 0.14% | 102 |
|
|
2024
Q1 | $17.2M | Buy |
64,576
+46,479
| +257% | +$12.4M | 0.09% | 157 |
|
|
2023
Q4 | $4.19M | Sell |
18,097
-1,767
| -9% | -$409K | 0.02% | 265 |
|
|
2023
Q3 | $2.9M | Buy |
19,864
+456
| +2% | +$66.6K | 0.02% | 291 |
|
|
2023
Q2 | $4.48M | Sell |
19,408
-1,458
| -7% | -$337K | 0.02% | 259 |
|
|
2023
Q1 | $5.05M | Buy |
20,866
+4,746
| +29% | +$1.15M | 0.03% | 254 |
|
|
2022
Q4 | $4.68M | Buy |
+16,120
| New | +$4.68M | 0.03% | 267 |
|
|
2019
Q3 | – | Sell |
-11,000
| Closed | -$1.15M | – | 522 |
|
|
2019
Q2 | $1.15M | Sell |
11,000
-7,333
| -40% | -$769K | ﹤0.01% | 331 |
|
|
2019
Q1 | $2.3M | Sell |
18,333
-195
| -1% | -$24.4K | 0.01% | 276 |
|
|
2018
Q4 | $2.09M | Buy |
18,528
+5,782
| +45% | +$652K | 0.01% | 280 |
|
|
2018
Q3 | $2.73M | Sell |
12,746
-2,282
| -15% | -$489K | 0.01% | 265 |
|
|
2018
Q2 | $4.2M | Buy |
15,028
+6,028
| +67% | +$1.69M | 0.02% | 239 |
|
|
2018
Q1 | $1.05M | Buy |
9,000
+3,000
| +50% | +$350K | ﹤0.01% | 333 |
|
|
2017
Q4 | $551K | Buy |
+6,000
| New | +$551K | ﹤0.01% | 365 |
|